Aspirin & Preeclampsia: Prevention Benefits
- MINNEAPOLIS — Prescribing low-dose aspirin universally, rather of relying on risk-based screenings, can improve preeclampsia prevention among underserved populations, according to research presented at the ACOG Annual Clinical...
- Ivie Odiase, an OB/GYN resident at mount Sinai West, noted that many of her patients with preeclampsia met the criteria for aspirin use.
- The retrospective analysis, conducted between February and May 2024, reviewed 116 patient charts (gestational age 12-28 weeks) from the SBH Wellness Center.
Boost preeclampsia prevention strategies. A recent study reveals that prescribing low-dose aspirin universally, rather than relying on risk-based screenings, can significantly improve health outcomes for underserved populations. Data from the ACOG Annual Clinical & Scientific Meeting highlights that universal implementation of low-dose aspirin increased the prescribing rate to 81%, an 81% jump. Researchers emphasize that such a simple step can lead to more equitable care. Dr. Ivie Odiase suggests that simple reminders can make a difference. News Directory 3 is committed to delivering crucial insights. Discover what’s next regarding universal candidacy and reduced preeclampsia rates.
Worldwide Aspirin Prescriptions Boost Preeclampsia Prevention
MINNEAPOLIS — Prescribing low-dose aspirin universally, rather of relying on risk-based screenings, can improve preeclampsia prevention among underserved populations, according to research presented at the ACOG Annual Clinical & Scientific Meeting.
dr. Ivie Odiase, an OB/GYN resident at mount Sinai West, noted that many of her patients with preeclampsia met the criteria for aspirin use. She and her team at St. Barnabas Hospital conducted a study to see if universal prescribing of low-dose aspirin increased its use for preeclampsia prevention.
The retrospective analysis, conducted between February and May 2024, reviewed 116 patient charts (gestational age 12-28 weeks) from the SBH Wellness Center. Researchers assessed patients for preeclampsia risk, aspirin eligibility, and whether aspirin had been prescribed.
ACOG guidelines recommend 81 mg of aspirin daily for pregnant patients at high risk for preeclampsia.
Odiase noted that while ACOG recommends universal aspirin in urban areas and high-risk populations, it can still be overlooked. The study found that 99% of patients were eligible for aspirin. After implementing universal prescribing, the overall prescribing rate jumped to 81%, an 81% increase from the previous 30%.
Researchers suggest that universal presumption of low-dose aspirin can increase its use in underserved communities, leading to more equitable care.odiase believes that simple reminders can make a difference.
Ivie Odiase
odiase suggests that having printed guidelines or dot phrases in electronic medical records can definitely help obstetricians remember to address preeclampsia risk amid other concerns. Future studies will explore how universal candidacy can further reduce preeclampsia rates.
Odiase and her colleagues plan to conduct a retrospective analysis at Mount Sinai west to assess aspirin prescription rates. She emphasized the importance of proactively identifying areas for advancement in patient care.
For more facts, dr. Ivie odiase can be reached at womenshealth@healio.com.
Source
Odiase I, et al. Increasing the use of low-dose aspirin for preeclampsia prevention through universal implementation. Presented at: ACOG Annual Clinical & Scientific Meeting; May 16-18, 2025; Minneapolis.
odiase and colleagues report no relevant financial disclosures.